The antibody anselamimab, which AstraZeneca picked up in its 2021 purchase of Caelum Biosciences, failed to improve survival and reduce hospitalizations, but the company sees promise in data from an ...

AstraZeneca Plc (NASDAQ:AZN) released high-level results from the Cardiac Amyloid Reaching for Extended Survival (CARES) ...

Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...

Tesla registered plans for a new six-seater Model Y L in China with a wheelbase of 3,040 mm, according to filing information published on China's industry ministry website on Wednesday. Tesla also ...

The deal will see Apple and MP Materials launch a recycling facility for processing recycled rare earth elements. Once ...